Zimmer Biomet Named “2017 Top Employer” in China by Top Employer Institute for Sixth Consecutive Year

SINGAPORE, Dec. 6, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the Company has been selected as China’s Top Employer for the sixth consecutive year by the Top Employers Institute, a global publishing organization specializing in research into best business practices and identifying leaders in the field of human resources, strategy and leadership.

Logo

“We are honored to be named Top Employer in China for the sixth year in a row, with the added distinction of being the only orthopaedic company to receive this prestigious recognition,” said Li Yong Ming, Vice President of Zimmer Biomet China & Hong Kong. “Zimmer Biomet places a great deal of emphasis and commitment on professional development and growth to ensure that our employees are motivated, engaged and invested in the success of our organization. We strive to promote a corporate culture that is authentic, positive and truly represents who we are as employers and reflects the core values that shape Zimmer Biomet’s organizational behaviors.”

The Top Employers certification is awarded to organizations that achieve the highest standards of excellence in employee conditions. Companies are vetted through a comprehensive research process anchored by a Human Resources (HR) Best Practices Survey, and followed by a validation process and an external audit to confirm the survey findings. Each company’s performance score is rated against an international standard, and only employers who achieve the required level earn the Top Employer certification.

“Creating a high-performance culture and nurturing environment where our team members can grow has been one of Zimmer Biomet’s key development plans to expand our businesses in the Asia Pacific region,” said Sang Yi, President of Zimmer Biomet Asia Pacific. “The Top Employers Institute recognition plays a vital role in shaping strategies for Zimmer Biomet’s next phase of growth in China by helping to attract and retain top talent, and continue to make a positive impact on our customers.”

About the Top Employers Institute

The Top Employers Institute is an independent organization headquartered in Holland. The Institute has been studying the human resources programs of major employers around the world since 1991. The Institute recognizes “Top Employers” through a comprehensive audit of a company’s human resources environment, including strategy, policy implementation, monitoring and employee development.  Individual company results are rated against international standards.  For more information, please visit http://www.top-employers.com.

About  Zimmer Biomet

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes.  Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially.  For a list and description of some of such risks and uncertainties, see our periodic reports filed with the SEC.  These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet’s filings with the SEC.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Accordingly, such forward-looking statements speak only as of the date made.  Readers of this news release are cautioned not to place undue reliance on these forward-looking statements, since, while management believes the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this news release.

Contact:

Jason Lee
+65 90084780
Jason.lee@zimmerbiomet.com

Logo – http://photos.prnasia.com/prnh/20161201/8521607821Logo